Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: mauser96 who wrote (3603)	6/20/1998 10:09:00 AM
From: Perry	Read Replies (1) \| Respond to of 9523

" The news about the FDA hit the market at 2:45 PM Eastern time, and by the close PFE had already recovered half it's losses, so I think we have already seen the professional response to the news. There is a fair chance of a sharp downward pressure right after the market opens Monday as the general public reacts (having had all weekend to worry). If that happens I will buy more. I don't think this news makes much difference long term." Lucius, you may be right about the early sell off but on the other hand I think many small investors, such as myself, will hold PFE at least until the Rx data gets released later on Monday. We keep on hearing about sustainable Rx rates by the analyst being at the 100,000 level, but last weeks Rx numbers clearly indicate that the demand for Viagra is, at the very least, stabilizing at the 200,000 to 300,000 level. This is huge for PFE. Perry PS it would be irresponsible for PFE to limit their press release to the short comments that we have read so far. The street hates uncertainty and therefore the exact reasons, good or bad, for the Zeldox denial must be released so that we can get past this. It was a very big surprise that a company as large as PFE can miss the mark on a new drug submission. Does anyone have any numbers on the big pharma co. (e.g. MRK, LLY, PFE) percentage of approvals and denials for NDAs?

To: mauser96 who wrote (3603)	6/20/1998 1:49:00 PM
From: coyote	Read Replies (2) \| Respond to of 9523

you said Each country makes it's own rules about when to allow a drug on the market in that country. I don't know about the specific case of Zeldox, but the general rule is that the FDA is tougher than similar agencies abroad, so that new drugs are usually available in other countries first. This isn't always the case- for instance Viagra has yet to be approved in Canada. Many countries could save their taxpayers a lot of money by automatic approval if the USA approves. If Canada had done that, we would have experienced all the thalidomide problems that you had. NO THANKS